Filing Details
- Accession Number:
- 0001567619-18-003657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-03 17:05:02
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-03 17:05:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581720 | Loxo Oncology Inc. | LOXO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1536368 | Anne Lori Kunkel | C/O Loxo Oncology, Inc. One Landmark Square, Suite 1122 Stamford CT 06901 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-01 | 5,000 | $3.65 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-10-01 | 4,500 | $170.20 | 500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 500 | $171.90 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (Right to Buy) | Disposition | 2018-10-01 | 5,000 | $0.00 | 5,000 | $3.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
22,344 | 2024-06-18 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- Represents the aggregate of sales effected on the same day at different prices.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.38 to $172.03 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock option is fully vested and is immediately exercisable.